Plato Investment Management Ltd purchased a new stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 6,529 shares of the technology company’s stock, valued at approximately $1,152,000.
Several other institutional investors have also recently made changes to their positions in VEEV. Williams Jones Wealth Management LLC. increased its holdings in Veeva Systems by 0.4% in the 3rd quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock worth $2,806,000 after acquiring an additional 40 shares in the last quarter. Rafferty Asset Management LLC boosted its position in shares of Veeva Systems by 0.7% in the second quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company’s stock worth $1,982,000 after purchasing an additional 51 shares during the period. Brown Brothers Harriman & Co. increased its stake in shares of Veeva Systems by 8.1% in the third quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock worth $214,000 after purchasing an additional 54 shares in the last quarter. Main Management ETF Advisors LLC increased its stake in shares of Veeva Systems by 1.0% in the fourth quarter. Main Management ETF Advisors LLC now owns 5,481 shares of the technology company’s stock worth $1,224,000 after purchasing an additional 56 shares in the last quarter. Finally, Root Financial Partners LLC raised its position in shares of Veeva Systems by 17.1% during the 4th quarter. Root Financial Partners LLC now owns 383 shares of the technology company’s stock valued at $85,000 after purchasing an additional 56 shares during the period. Institutional investors own 88.20% of the company’s stock.
Key Headlines Impacting Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Analyst price targets raised: Barclays lifted its target from $235 to $275 and assigned an “overweight” rating. Oppenheimer raised its target from $225 to $300 with an “outperform” rating, while Stifel increased its target from $230 to $275 and issued a “buy” rating. These upgrades indicate improving confidence in Veeva’s growth prospects. Benzinga analyst price-target reports
- Positive Sentiment: Solid operating momentum: Veeva’s latest quarterly results exceeded consensus estimates, with earnings per share of $2.24 versus $2.14 expected and revenue of $882.95 million versus $857.73 million expected. Revenue grew 16.3% year over year, and management provided fiscal 2027 earnings guidance. Veeva Systems financial and earnings information
- Positive Sentiment: Institutional support: Major investors, including Norges Bank, Durable Capital Partners, Arrowstreet Capital, AQR Capital Management and Swedbank, recently established or increased positions. Institutions own approximately 88.2% of outstanding shares, suggesting substantial professional-investor participation.
- Neutral Sentiment: A related article identified Veeva as one of two potentially better investments than privately held SpaceX, which may improve investor attention but does not represent a new company-specific development. Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets
- Negative Sentiment: Insider selling: Director Thomas Schwenger sold 36,000 shares worth approximately $9.0 million, reducing his stake by 64.9%. Because the transaction occurred under a pre-arranged Rule 10b5-1 plan, it may be less concerning than discretionary selling, but it could still weigh on sentiment.
Insiders Place Their Bets
Veeva Systems Stock Performance
Shares of NYSE VEEV opened at $243.33 on Wednesday. The company has a market cap of $39.53 billion, a P/E ratio of 43.37, a P/E/G ratio of 1.05 and a beta of 0.92. The firm’s fifty day moving average is $192.90 and its two-hundred day moving average is $180.87. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The business had revenue of $882.95 million during the quarter, compared to the consensus estimate of $857.73 million. During the same quarter in the prior year, the firm earned $1.97 EPS. The business’s revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, analysts forecast that Veeva Systems Inc. will post 6.65 EPS for the current fiscal year.
Wall Street Analyst Weigh In
VEEV has been the subject of several recent analyst reports. Barclays upped their target price on shares of Veeva Systems from $235.00 to $275.00 and gave the stock an “overweight” rating in a report on Tuesday. BNP Paribas Exane reissued an “outperform” rating and set a $285.00 price target on shares of Veeva Systems in a report on Thursday, June 4th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $275.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. BTIG Research reiterated a “buy” rating and set a $340.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Finally, BMO Capital Markets decreased their target price on Veeva Systems from $220.00 to $175.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $253.75.
Read Our Latest Report on Veeva Systems
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
